Palantir’s Record Quarter Meets a Wall of Worry: Yields, Valuation, and Insider Sales Eclipse a Ukraine Showcase

Palantir delivered its strongest financial quarter ever — revenue up 85% to $1.633 billion, net income surging to $870.5 million, and a GAAP margin hitting 53%. The stock has nonetheless lost more than a fifth of its value since the start of the year, falling to around 111-113 euros in European trading. The disconnect between operating momentum and market performance is not a mystery: it is a collision of macro headwinds, extreme valuation, insider selling, and intensifying competition.

Bond markets have turned into an invisible drag. The yield on the 10-year US Treasury climbed to 4.49% after a hot producer price report, and long-duration bonds briefly breached 5%. For a stock trading at roughly 42 times projected 2026 sales and 93 times expected earnings, higher discount rates cut directly into the present value of those distant cash flows. Even a 98% jump in remaining contract value to $11.8 billion — or the $4.5 billion in remaining performance obligations — cannot fully offset that arithmetic.

Inside the company, the business story remains compelling. US commercial revenue accelerated 133% year-over-year, the strongest proof yet that Palantir is broadening beyond government clients. Management raised its full-year guidance to $7.66 billion, implying 71% growth and topping analyst estimates. On May 12, CEO Alex Karp was in Kyiv meeting President Zelensky to expand AI cooperation for military and civilian uses. Ukraine’s Brave1 Dataroom platform now gives more than 100 companies access to real battlefield data for training over 80 AI models dedicated to air defense. The country functions as a global reference client — when defense ministries in the US or Europe compare Palantir against Microsoft, Alphabet, or IBM, that live proof of concept weighs heavily.

Should investors sell immediately? Or is it worth buying Palantir?

Yet the stock’s price tag has become its own liability. At the start of the year, Palantir carried a price-to-earnings ratio of 155. After the post-earnings drop — the shares fell from $144 to $134 the day after the quarterly report — the multiple is still about 154 times trailing earnings. Argus reiterated a buy this week with a $190 target, calling the pullback an entry opportunity. But the consensus average price target of around $195 (or $183.73, depending on the sample) sits far from the current level, and analysts on the bearish side point to Anthropic and OpenAI adopting integration strategies that encroach on Palantir’s traditional strengths.

Insider activity adds another layer of unease. Stock-based compensation hit $684 million in 2024, while share buybacks totaled just $75 million. Co-founder Peter Thiel sold roughly two million shares in early March at prices between $141 and $147. The S&P 500 is near record highs, and capital is rotating into laggards — which makes Palantir, after its parabolic run in 2025, a natural source of funds for rebalancing.

The next crucial test comes with second-quarter results. Management targets around $1.8 billion in revenue. Whether that is enough to reset the valuation debate depends on whether growth can accelerate enough to silence the discount-rate hawks and how much conviction institutional investors still have in a stock trading at a premium that leaves little room for error.